A twist is evident in the title compound, C 21 H 21 N 3 O 2 , the dihedral angle between the terminal six-membered rings being 29.46 (10) ; the linked five-and six-membered rings are coplanar [1.30 (11) ]. The carbonyl O atom accepts intramolecular hydrogen bonds from the adjacent hydroxy and amine groups. The three-dimensional crystal packing is achieved through C-HÁ Á Á interactions.
Related literature
For background to the synthesis, see: Gelin et al. (1983) ; Bendaas et al. (1999) . For the structures of the 4-chloro and 4-methoxy analogues, see: Asiri, Al-Youbi, Alamry et al. H atoms treated by a mixture of independent and constrained refinement Á max = 0.24 e Å À3 Á min = À0.29 e Å À3 Table 1 Hydrogen-bond geometry (Å , ).
Cg1 and Cg2 are the centroids of the C1-C6 and C15-C20 rings, respectively. Symmetry codes: (i) Àx þ 1; y À 1 2 ; Àz þ 1 2 ; (ii) Àx þ 1; y þ 1 2 ; Àz þ 1 2 ; (iii) Àx; y À 1 2 , Àz þ 1 2 .
Data collection: CrysAlis PRO (Agilent, 2011); cell refinement: CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 (Farrugia, 1997) and DIAMOND (Brandenburg, 2006) ; software used to prepare material for publication: publCIF (Westrip, 2010). 
Comment
In connection with recent structural studies (Asiri, Al-Youbi, Alamry et al., 2011; (Asiri, Al-Youbi, Faidallah et al., 2011) of compounds prepared by reactions between pyrazoles and aniline derivatives following literature procedures (Gelin et al., 1983; Bendaas et al., 1999) , the title compound, 3-(4-toluidino)-1-(5-hydroxy-3-methyl-1-phenyl-1H-pyrazol-4yl)but-2-en-1-one (I) was investigated.
While in (I), Fig. 1 , the linked five-and six-membered rings are co-planar, forming a dihedral angle of 1.30 (11)°, there is a twist about the N3-C15 bond as seen in the value of the C13-N3-C15-C16 torsion angle of 146.9 (2)°; the dihedral angle between the terminal six-membered rings is 29.46 (10)°. The carbonyl-O2 atom accepts hydrogen bonds from the adjacent hydroxyl-and amine-groups, Table 1 . These groups do not participate in intermolecular interactions.
Rather, molecules are consolidated in the three-dimensional crystal packing by C-H···π interactions, Fig. 2 and Table 1 .
Experimental
A solution of 4-acetoacetyl-5-hydroxy-3-methyl-1-phenylpyrazole (0.005 mol) and p-toluidine (0.005 mol) in ethanol (25 ml) was refluxed for 2 h. The precipitate, obtained from the hot solution, was collected, washed with methanol and recrystallized from its ethanol-benzene solution as yellow needles; M.pt: 419-421 K.
Refinement
Carbon-bound H-atoms were placed in calculated positions [C-H = 0.95 to 0.98 Å, U iso (H) = 1.2 to 1.5U eq (C)] and were included in the refinement in the riding model approximation. The N-H and O-H-atoms were located in a difference Fourier map, and were refined with distance restraints of N-H = 0.88±0.01 and O-H = 0.84±0.01 Å, respectively; their U iso values were refined. Owing to poor agreement, the (3 6 3) reflection was omitted from the final cycles of refinement.
Computing details
Data collection: CrysAlis PRO (Agilent, 2011); cell refinement: CrysAlis PRO (Agilent, 2011); data reduction: CrysAlis PRO (Agilent, 2011); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 (Farrugia, 1997) and DIAMOND (Brandenburg, 2006) ; software used to prepare material for publication: publCIF (Westrip, 2010). supplementary materials sup-2 Acta Cryst. (2012). E68, o794
Figure 1
The molecular structure of (I) showing the atom-labelling scheme and displacement ellipsoids at the 50% probability level.
Figure 2
A view in projection down the a axis of the unit-cell contents of (I). The C-H···π interactions are shown as purple dashed lines. Hydrogen-bond geometry (Å, º) Cg1 and Cg2 are the centroids of the C1-C6 and C15-C20 rings, respectively. Symmetry codes: (i) −x+1, y−1/2, −z+1/2; (ii) −x+1, y+1/2, −z+1/2; (iii) −x, y−1/2, −z+1/2.
(2Z)-1-(5-Hydroxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)-3-(4-methylanilino)but-2-en-1-one

